Bar Plot from Scientific Research

Percentage of patients with 80-ms reduction in cT1 (TERN-501 1 mg, P = 0.9645; TERN-501 3 mg, P = 0.09645; TERN-501 6 mg, P = 0.0449) at week 12 for TERN-501 monotherapy groups. P values were obtained using a chi-square test. Comparison between groups was conducted at the two-sided, 0.05 level of significance. No adjustments for multiplicity were made. * P < 0.05; ** P < 0.01; *** P < 0.001 for TERN-501 monotherapy versus placebo.

DOI